SEC Form 4 · accession 0001179110-15-006376
HEALTH NET INC · HNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Woys
Officer — EVP, CFO and COO
Period of report
Apr 14, 2015
Accepted (ET)
Apr 16, 2015 · 5:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000916085
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Apr 14, 2015 | M | 17,000 | $32.59 | A | 380,012 | D | |
| Common StockF3,F2 | Apr 14, 2015 | S | 17,000 | $57.93 | D | 363,012 | D | |
| Common StockF2 | Apr 15, 2015 | M | 17,000 | $32.59 | A | 380,012 | D | |
| Common StockF4,F2 | Apr 15, 2015 | S | 12,100 | $56.50 | D | 367,912 | D | |
| Common StockF5,F2 | Apr 15, 2015 | S | 3,900 | $57.77 | D | 364,012 | D | |
| Common StockF6,F2 | Apr 15, 2015 | S | 1,000 | $58.32 | D | 363,012 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F7 | $32.59 | Apr 14, 2015 | M | 17,000 | D | — | May 13, 2015 | Common Stock | 17,000 | 49,000 | D |
| Stock Option (Right to Buy)F7 | $32.59 | Apr 15, 2015 | M | 17,000 | D | — | May 13, 2015 | Common Stock | 17,000 | 32,000 | D |
Explanation of responses
- F1Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 13, 2005 under the Issuer's 2005 Long-Term Incentive Plan, as amended (the "2005 Grant"), in a transaction exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Act"). The exercise of the 2005 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- F2Includes 5,450 shares in which the Reporting Person has a beneficial interest under the profit-sharing component of the Issuer's 401(k) Savings Plan.
- F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.69 to $58.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.14 to $57.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- F5The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.19 to $58.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- F6The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.21 to $58.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- F7The 2005 Grant became exercisable in 25% increments on each of the first, second, third, and fourth anniversaries of May 13, 2005, the grant date.